XML 54 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Product revenues:      
Related party $ 0us-gaap_RevenueFromRelatedParties $ 1,845,000us-gaap_RevenueFromRelatedParties $ 0us-gaap_RevenueFromRelatedParties
Third party 4,953,000us-gaap_SalesRevenueGoodsNet 5,277,000us-gaap_SalesRevenueGoodsNet 8,709,000us-gaap_SalesRevenueGoodsNet
Total product revenues 4,953,000us-gaap_Revenues 7,122,000us-gaap_Revenues 8,709,000us-gaap_Revenues
Cost of product revenues 2,940,000us-gaap_CostOfGoodsSold 3,421,000us-gaap_CostOfGoodsSold 4,000,000us-gaap_CostOfGoodsSold
Gross profit 2,013,000us-gaap_GrossProfit 3,701,000us-gaap_GrossProfit 4,709,000us-gaap_GrossProfit
Development revenues:      
Development, related party 0cytx_DevelopmentRelatedParty 638,000cytx_DevelopmentRelatedParty 2,882,000cytx_DevelopmentRelatedParty
Development 0cytx_Development 1,179,000cytx_Development 2,529,000cytx_Development
Government contracts and other 2,645,000cytx_GovernmentContractsAndOther 3,257,000cytx_GovernmentContractsAndOther 381,000cytx_GovernmentContractsAndOther
Total development revenues 2,645,000cytx_TotalDevelopmentRevenues 5,074,000cytx_TotalDevelopmentRevenues 5,792,000cytx_TotalDevelopmentRevenues
Operating expenses:      
Research and development 15,105,000us-gaap_ResearchAndDevelopmentExpense 17,065,000us-gaap_ResearchAndDevelopmentExpense 13,628,000us-gaap_ResearchAndDevelopmentExpense
Sales and marketing 6,406,000us-gaap_SellingAndMarketingExpense 9,026,000us-gaap_SellingAndMarketingExpense 9,488,000us-gaap_SellingAndMarketingExpense
General and administrative 15,953,000us-gaap_GeneralAndAdministrativeExpense 16,031,000us-gaap_GeneralAndAdministrativeExpense 15,672,000us-gaap_GeneralAndAdministrativeExpense
Change in fair value of warrants (369,000)us-gaap_FairValueAdjustmentOfWarrants (418,000)us-gaap_FairValueAdjustmentOfWarrants (209,000)us-gaap_FairValueAdjustmentOfWarrants
Change in fair value of option liability 0cytx_ChangeInFairValueOfOptionLiability (2,250,000)cytx_ChangeInFairValueOfOptionLiability 340,000cytx_ChangeInFairValueOfOptionLiability
Total operating expenses 37,095,000us-gaap_OperatingExpenses 39,454,000us-gaap_OperatingExpenses 38,919,000us-gaap_OperatingExpenses
Operating loss (32,437,000)us-gaap_OperatingIncomeLoss (30,679,000)us-gaap_OperatingIncomeLoss (28,418,000)us-gaap_OperatingIncomeLoss
Other income (expense):      
Gain (loss) on asset disposal 42,000us-gaap_GainLossOnDispositionOfAssets (257,000)us-gaap_GainLossOnDispositionOfAssets 0us-gaap_GainLossOnDispositionOfAssets
Loss on debt extinguishment 0us-gaap_ExtinguishmentOfDebtGainLossNetOfTax (708,000)us-gaap_ExtinguishmentOfDebtGainLossNetOfTax 0us-gaap_ExtinguishmentOfDebtGainLossNetOfTax
Interest income 6,000us-gaap_InvestmentIncomeInterest 4,000us-gaap_InvestmentIncomeInterest 4,000us-gaap_InvestmentIncomeInterest
Interest expense (4,371,000)us-gaap_InterestExpense (3,396,000)us-gaap_InterestExpense (3,386,000)us-gaap_InterestExpense
Other income (expense), net (608,000)us-gaap_OtherNonoperatingIncomeExpense (438,000)us-gaap_OtherNonoperatingIncomeExpense (314,000)us-gaap_OtherNonoperatingIncomeExpense
Gain on Puregraft divestiture 0cytx_GainLossOnSaleOfProductLineAsset 4,453,000cytx_GainLossOnSaleOfProductLineAsset 0cytx_GainLossOnSaleOfProductLineAsset
Gain on previously held equity interest in joint venture 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain 4,892,000us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
Equity loss from investment in joint venture 0us-gaap_IncomeLossFromEquityMethodInvestments (48,000)us-gaap_IncomeLossFromEquityMethodInvestments (165,000)us-gaap_IncomeLossFromEquityMethodInvestments
Total other income (expense) (4,931,000)us-gaap_NonoperatingIncomeExpense 4,502,000us-gaap_NonoperatingIncomeExpense (3,861,000)us-gaap_NonoperatingIncomeExpense
Net loss (37,368,000)us-gaap_NetIncomeLoss (26,177,000)us-gaap_NetIncomeLoss (32,279,000)us-gaap_NetIncomeLoss
Beneficial conversion feature for convertible preferred stock (1,169,000)us-gaap_PreferredStockDividendsAndOtherAdjustments 0us-gaap_PreferredStockDividendsAndOtherAdjustments 0us-gaap_PreferredStockDividendsAndOtherAdjustments
Net loss allocable to common stock holders (38,537,000)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic (26,177,000)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic (32,279,000)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Basic and diluted net loss per share allocable to common stockholders $ (0.48)us-gaap_EarningsPerShareBasicAndDiluted $ (0.39)us-gaap_EarningsPerShareBasicAndDiluted $ (0.55)us-gaap_EarningsPerShareBasicAndDiluted
Basic and diluted weighted average shares used in calculating net loss per share allocable to common stockholders 80,830,698us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 67,781,364us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 58,679,687us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted
Other comprehensive income - foreign currency translation adjustments 444,000us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax 256,000us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax 0us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
Comprehensive loss $ (36,924,000)us-gaap_ComprehensiveIncomeNetOfTax $ (25,921,000)us-gaap_ComprehensiveIncomeNetOfTax $ (32,279,000)us-gaap_ComprehensiveIncomeNetOfTax